PubRank

B Bendriem

Author PubWeight™ 40.01‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab 1990 6.62
2 Physical and clinical performance of the mCT time-of-flight PET/CT scanner. Phys Med Biol 2011 3.14
3 Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry 1991 2.89
4 Concept of reaction volume in the in vivo ligand-receptor model. J Nucl Med 1996 2.01
5 Peduncular 'rubral' tremor and dopaminergic denervation: a PET study. Neurology 1995 1.84
6 Quantitative imaging of iodine-124 with PET. J Nucl Med 1996 1.69
7 Effects of chronic cocaine abuse on postsynaptic dopamine receptors. Am J Psychiatry 1990 1.66
8 Respective roles of scatter, attenuation, depth-dependent collimator response and finite spatial resolution in cardiac single-photon emission tomography quantitation: a Monte Carlo study. Eur J Nucl Med 1999 1.59
9 Mapping cocaine binding sites in human and baboon brain in vivo. Synapse 1989 1.29
10 Design and performance of POSICAM 6.5 BGO positron camera. J Nucl Med 1990 1.18
11 In vivo imaging of oligonucleotides with positron emission tomography. Nat Med 1998 1.15
12 PET scanning of iodine-124-3F9 as an approach to tumor dosimetry during treatment planning for radioimmunotherapy in a child with neuroblastoma. J Nucl Med 1992 1.10
13 Quantification of benzodiazepine receptors in human brain using PET, [11C]flumazenil, and a single-experiment protocol. J Cereb Blood Flow Metab 1995 0.96
14 Quantitation of extrastriatal D2 receptors using a very high-affinity ligand (FLB 457) and the multi-injection approach. J Cereb Blood Flow Metab 1999 0.89
15 A hybrid scatter correction for 3D PET based on an estimation of the distribution of unscattered coincidences: implementation on the ECAT EXACT HR+. Phys Med Biol 2002 0.86
16 Modeling analysis of [11C]flumazenil kinetics studied by PET: application to a critical study of the equilibrium approaches. J Cereb Blood Flow Metab 1993 0.83
17 Robustness of anatomically guided pixel-by-pixel algorithms for partial volume effect correction in positron emission tomography. J Cereb Blood Flow Metab 1999 0.83
18 Age-related decreases in muscarinic cholinergic receptor binding in the human brain measured with positron emission tomography (PET). J Neurosci Res 1990 0.83
19 A technique for the correction of scattered radiation in a PET system using time-of-flight information. J Comput Assist Tomogr 1986 0.83
20 Fast nonsupervised 3D registration of PET and MR images of the brain. J Cereb Blood Flow Metab 1994 0.82
21 Parametric images of benzodiazepine receptor concentration using a partial-saturation injection. J Cereb Blood Flow Metab 1997 0.81
22 Quantification of myocardial muscarinic receptors with PET in humans. J Nucl Med 1993 0.81
23 Parameter and index images of benzodiazepine receptor concentration in the brain. J Nucl Med 1995 0.78
24 Quantitation of benzodiazepine receptors in human brain using the partial saturation method. J Nucl Med 1996 0.78
25 Bromine-76-metabromobenzylguanidine: a PET radiotracer for mapping sympathetic nerves of the heart. J Nucl Med 1993 0.78
26 Dosimetry of transmission measurements in nuclear medicine: a study using anthropomorphic phantoms and thermoluminescent dosimeters. Eur J Nucl Med 1998 0.78
27 Mapping muscarinic receptors in human and baboon brain using [N-11C-methyl]-benztropine. Synapse 1990 0.78
28 Assessment of coronary reserve in man: comparison between positron emission tomography with oxygen-15-labeled water and intracoronary Doppler technique. J Nucl Med 1993 0.78
29 Comparison of fluorine-18 and bromine-76 imaging in positron emission tomography. Eur J Nucl Med 1999 0.77
30 Absolute quantitation of iodine-123 epidepride kinetics using single-photon emission tomography: comparison with carbon-11 epidepride and positron emission tomography. Eur J Nucl Med 1999 0.75
31 Reaction volume concept. J Nucl Med 1997 0.75
32 Should scatter be corrected in both transmission and emission data for accurate quantitation in cardiac SPET? Eur J Nucl Med 2000 0.75
33 Comparison of clinical data sets acquired on different tomographs using 6-18F-L-dopa. Eur J Nucl Med 2000 0.75
34 Iterative crystal efficiency calculation in fully 3-D PET. IEEE Trans Med Imaging 2000 0.75
35 Regional distribution and kinetics of haloperidol binding in human brain: a PET study with [18F]haloperidol. Synapse 1992 0.75
36 [Fluorodeoxyglucose and bronchopulmonary cancer. Initial French results with positron emission tomography]. Rev Pneumol Clin 1998 0.75
37 Validation of the three-dimensional acquisition mode in positron emission tomography for the quantitation of [18F]fluoro-DOPA uptake in the human striata. J Cereb Blood Flow Metab 1998 0.75
38 Positron emission tomography: basic principles and applications in psychiatric research. Ann N Y Acad Sci 1991 0.75
39 Positron emission tomography instrumentation: an overview. Am J Physiol Imaging 1988 0.75
40 The approximate inverse and conjugate gradient: non-symmetrical algorithms for fast attenuation correction in SPECT. Phys Med Biol 1995 0.75